Polypharmacy in the elderly complicates therapy, increases cost, and is a challenge for healthcare agencies. In the context of the evolving role of the pharmacist, this systematic review examines the effectiveness of interventions led by pharmacists in reducing polypharmacy.
A computerised search was conducted using Medline, Embase geriatrics and gerontology (2001 edition), the Cochrane Library and International Pharmaceutical Abstracts (IPA) databases. A manual search of articles on polypharmacy and the role of pharmacists in the therapy of the elderly and of the reference sections of all retrieved articles was also carried out. Search terms used were ‘polypharmacy’, ‘elderly’, ‘aged’, ‘intervention’ and ‘pharmacist(s)’. Articles that fulfilled the following criteria were included: only elderly people were included in the study, or all ages were included but the study gave separate results for the elderly; the outcome was expressed as a reduction in the number of medications; a pharmacist participated in the study; and the study was a controlled or a randomised controlled study.
We initially identified 106 articles, but only 14 studies met our four inclusion criteria. Reduction in the number of medications was not the major purpose of most selected studies but often a secondary outcome. Objectives differed, the general aim being to enhance the quality of prescribing in elderly patients. These controlled studies argued in favour of the effectiveness of pharmacists’ interventions, even though the number of medications eliminated was small. Most studies were not designed to demonstrate the impact of reducing the number of drugs on the clinical consequences of polypharmacy (nonadherence, adverse drug reactions, drug-drug interactions, increased risk of hospitalisation, and medication errors).
The most frequently reported outcome related to cost savings. It was therefore difficult to assess whether the interventions benefited the patient. The methodological quality of many identified studies was poor. In particular, the study objectives were often very broad and ill-defined. Polypharmacy itself has been defined in different ways and the appropriate definition may differ according to the patient population and the study setting.
Further studies are needed to find the most effective way to reduce polypharmacy, especially in the frail elderly population, and to quantify the real advantages of simplifying their drug regimens in terms of improved quality of life.
Nursing Home Adverse Drug Reaction Medication Error Nursing Home Resident Pharmaceutical Care
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.
No sources of funding were used to assist in the preparation of this manuscript. The authors have no conflicts of interest that are directly relevant to the content of this manuscript.
McLeod DC. Contribution of clinical pharmacists to patient care. Am J Hosp Pharm1976; 33: 904–11PubMedGoogle Scholar
American College of Physicians, American Society of Internal Medicine. Pharmacist scope of practice. Ann Intern Med 2002; 136: 79–85Google Scholar
Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990; 47: 533–43PubMedGoogle Scholar
Omori DM, Potyk RP, Kroenke K. The adverse effects of hospitalisation on drug regimens. Arch Intern Med 1991; 151: 1562–4PubMedCrossRefGoogle Scholar
Kroenke K, Pinholt EM. Reducing polypharmacy in the elderly: a controlled trial of physician feedback. J Am Geriatr Soc 1990; 38: 31–6PubMedGoogle Scholar
Meyer TJ, Van Kooten D, Marsh S, et al. Reduction of polypharmacy by feedback to clinicians. J Gen Intern Med 1991; 6: 133–6PubMedCrossRefGoogle Scholar
Montamat SC, Cusack B. Overcoming problems with polypharmacy and drug misuse in the elderly. Clin Geriatr Med 1992; 8(1): 143–58PubMedGoogle Scholar
Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49(2): 200–9PubMedCrossRefGoogle Scholar
Beers MH, Munekata M, Storrie M. The accuracy of medication histories in the hospital medical records of elderly persons. J Am Geriatr Soc 1990; 38: 1183–7PubMedGoogle Scholar
Barat I, Andreasen F, Damsgaard EMS. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol 2000; 56: 501–9PubMedCrossRefGoogle Scholar
Lamy PP. New dimensions and opportunities. Drug Intell Clin Pharm 1985; 19: 399–402PubMedGoogle Scholar
Kennerfalk A, Ruigomez A, Wallander MA, et al. Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 2002; 36: 797–803PubMedCrossRefGoogle Scholar
Thomas HF, Sweetnam PM, Janchawee B, et al. Polypharmacy among older males in South Wales. Eur J Clin Pharmacol 1999; 55: 411–5PubMedCrossRefGoogle Scholar
Bjerrum L, Sogaard J, Hallas J,et al. Polypharmacy: correlation with sex, age and drug regimen. Eur J Clin Pharmacol 1998; 54: 197–202PubMedCrossRefGoogle Scholar
Jeandel C, Graille M, Ferry JC. La prescription médicamenteuse chez la personne âgée: a propos d’une enquête dans la région Nord-Est. Rev Geriatr 1996; 21(7): 483–7Google Scholar
Fourrier A, Letenneur L, Dartigues J, et al. Consommation médicamenteuse chez le sujet âgé vivant à domicile et en institution à partir de la cohorte Paquid: importance de la polymédication et utilisation des psychotropes. Rev Geriatr 1996; 21(7): 473–82Google Scholar
Espino DV, Lichtenstein MJ, Hazuda HP, et al. Correlates of prescription and over-the-counter medication usage among older Mexican Americans: The Hispanic EPESE study. J Am Geriatr Soc 1998; 46: 1228–34PubMedGoogle Scholar
Blenkiron P. The elderly and their medication: understanding and compliance in a family practice. Postgrad Med J 1996; 72: 671–6PubMedCrossRefGoogle Scholar
Stoehr GP, Ganguli M, Seaberg EC, et al. Over-the-counter medication use in an older rural community: the MoVIES Project. J Am Geriatr Soc 1997; 45: 158–65PubMedGoogle Scholar
Gurwitz JH, Soumerai SB, Avorn J. Improving medication prescribing and utilization in the nursing home. J Am Geriatr Soc 1990; 38: 542–52PubMedGoogle Scholar
Broderick E. Prescribing patterns for nursing home residents in the US: the reality and the vision. Drugs Aging 1997; 11: 255–60PubMedCrossRefGoogle Scholar
Zuniga C. Prescription médicamenteuse chez la personne âgée à l’Hôpital de Gériatrie de Genève. Data on file, 1996Google Scholar
Beers MH, Drag J, Hasegawa J, et al. Influence of hospitalisation on drug therapy in the elderly. J Am Geriatr Soc 1989; 37: 679–83PubMedGoogle Scholar
Gupta S, Rappaport HM, Bennett LT. Polypharmacy among nursing home geriatric Medicaid recipients. Ann Pharmacother 1996; 30: 946–50PubMedGoogle Scholar
Tamblyn RM, McLeod PJ, Abrahamowicz M, et al. Do too many cooks spoil the broth? Multiple physician involvement in medical management in elderly patients and potentially inappropriate drug combinations. CMAJ 1996; 154: 1177–84PubMedGoogle Scholar
Tamblyn R. Medication use in seniors: challenges and solutions. Thérapie 1996; 51: 269–82PubMedGoogle Scholar
Harris CM, Dajda R. The scale of repeat prescribing. Br J Gen Pract 1996; 46: 649–53PubMedGoogle Scholar
Doucet J, Chassagne P, Trivalle C, et al. Drug-drug interactions related to hospital admissions in older adults: a prospective study of 1000 patients. J Am Geriatr Soc 1996; 44: 944–8PubMedGoogle Scholar
Lindley CM, Tully MP, Paramsothy V, et al. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing 1992; 21: 294–300PubMedCrossRefGoogle Scholar
Borchelt M. Potentielle Neben- und Wechselwirkungen der Multimedikation im Alter: Methodik und Ergebnisse des Berliner Alterstudie. Z Gerontol Geriatr 1995; 28: 420–8PubMedGoogle Scholar
Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841–5PubMedCrossRefGoogle Scholar
Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf 1993; 9(1): 51–9PubMedCrossRefGoogle Scholar
Colt HG, Shapiro AP. Drug-induced illness as a cause for admission to a community hospital. J Am Geriatr Soc 1989; 37: 323–6PubMedGoogle Scholar
Flaherty JH, Perry HM, Lynchard GS, et al. Polypharmacy and hospitalization among older home care patients. J Gerontol 2000; 55A(10): M554–9Google Scholar
American Society of Health-System Pharmacists. Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events and adverse drug reactions. Am J Health Syst Pharm 1998; 55: 165–6Google Scholar
Philips J, Beam S, Brinker A, et al. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001; 58: 1835–41Google Scholar
Monson RA, Bond CA. The accuracy of the medical record as an index of outpatient drug therapy. JAMA 1978; 240: 2182–4PubMedCrossRefGoogle Scholar
Sullivan SD, Kreling DH, Hazlet TK. Noncompliance with medication regimens and subsequent hospitalization: a literature analysis and cost of hospitalization estimate. J Res Pharm Econ 1992; 2: 19–33Google Scholar
Malhotra S, Karan RS, Pandhi P, et al. Drug related medical emergencies in the elderly: role of adverse drug reactions and non-compliance. Postgrad Med J 2001; 77: 703–7PubMedCrossRefGoogle Scholar
Allard J, Hebert R, Rioux M, et al. Efficacy of a clinical medication review on the number of potentially inappropriate prescriptions prescribed for community-dwelling elderly people. CMAJ 2001; 164(9): 1291–6PubMedGoogle Scholar
Furniss L, Bums A, Craig SKL, et al. Effects of a pharmacist’s medication review in nursing homes. Br J Pschiatry 2000; 176: 563–7CrossRefGoogle Scholar
Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med 1996; 100(4): 428–37PubMedCrossRefGoogle Scholar
Lipton HL, Bird JA. The impact of clinical pharmacists’ consultations on geriatric patients’ compliance and medical care use: a randomised controlled trial. Gerontologist 1994; 34(3): 307–15PubMedCrossRefGoogle Scholar
Owens NJ, Sherburne NJ, Silliman RA, et al. The Senior Care Study. The optimal use of medications in acutely ill older patients. J Am Geriatr Soc 1990; 38: 1082–7PubMedGoogle Scholar
Rubenstein LZ, Josephson K, Wieland D, et al. Geriatric assessment on a subacute hospital ward. Clin Geriatr Med 1987; 3: 131–43PubMedGoogle Scholar
Williams RG, McCoy R, Frederick KR. Impact of pharmacy consultant services to homebound population. Consult Pharm 1987; 2: 479–82Google Scholar
Zermansky AG, Petty DR, Raynor DK, et al. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ 2001; 323: 1–5CrossRefGoogle Scholar
Blakey SA, Hixson-Wallace JA. Clinical and economic effects of pharmacy services in a geriatric ambulatory clinic. Pharmacotherapy 2000; 20(10): 1198–203PubMedCrossRefGoogle Scholar
Hood JC, Lemberger M, Stewart RB. Promoting appropriate therapy in a long-term care facility. J Am Pharm Assoc 1975; 15: 32–33, 37PubMedGoogle Scholar
Karki SD, Mott P, Rosato L. Impact of a team approach on reducing polypharmacy. Consult Pharm 1991; 6: 133–7Google Scholar
Ruggiero RJ, Cohen KR, Lauletta J, et al. Further exploration of the economic impact of a pharmacist intervention at the point of polypharmacy prescribing: a follow-up study. Pharmacy and Therapeutics 1997; 22(11): 555–6, 558, 563–572, 578Google Scholar
Tamai IY, Rubenstein LZ, Josephson KR, et al. Impact of computerized drug profiles and a consulting pharmacist on outpatient prescribing patterns: a clinical trial. Drug Intell Clin Pharm 1987; 21(11): 890–5PubMedGoogle Scholar
Thompson JF, McGhan WF, Ruffalo RL, et al. Clinical pharmacists prescribing drug therapy in a geriatric setting: outcome of a trial. J Am Geriatr Soc 1984; 32(2): 154–9PubMedGoogle Scholar